Corient Private Wealth LLC Acquires Shares of 6,445 VanEck Biotech ETF (NASDAQ:BBH)

Corient Private Wealth LLC purchased a new position in shares of VanEck Biotech ETF (NASDAQ:BBHFree Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 6,445 shares of the company’s stock, valued at approximately $1,065,000. Corient Private Wealth LLC owned 0.23% of VanEck Biotech ETF at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in BBH. Anchor Investment Management LLC bought a new stake in shares of VanEck Biotech ETF during the 4th quarter worth approximately $26,000. Principal Securities Inc. bought a new stake in shares of VanEck Biotech ETF during the 4th quarter worth approximately $66,000. Howard Wealth Management LLC bought a new stake in shares of VanEck Biotech ETF during the 4th quarter worth approximately $201,000. Private Advisor Group LLC lifted its holdings in shares of VanEck Biotech ETF by 4.7% during the 3rd quarter. Private Advisor Group LLC now owns 1,675 shares of the company’s stock worth $261,000 after acquiring an additional 75 shares during the period. Finally, International Assets Investment Management LLC bought a new stake in shares of VanEck Biotech ETF during the 4th quarter worth approximately $305,000. Institutional investors own 32.05% of the company’s stock.

VanEck Biotech ETF Stock Up 0.5 %

Shares of VanEck Biotech ETF stock opened at $164.59 on Monday. The company has a 50 day moving average of $162.15 and a 200-day moving average of $162.36. VanEck Biotech ETF has a 1-year low of $142.51 and a 1-year high of $171.04.

About VanEck Biotech ETF

(Free Report)

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.

See Also

Want to see what other hedge funds are holding BBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VanEck Biotech ETF (NASDAQ:BBHFree Report).

Institutional Ownership by Quarter for VanEck Biotech ETF (NASDAQ:BBH)

Receive News & Ratings for VanEck Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.